Synonyms: AZ-3246 | compound 24 [PMID: 39928839]
Compound class:
Synthetic organic
Comment: AZ3246 is a selective inhibitor of hematopoietic progenitor kinase 1 (HPK1; MAP4K1) [1]. It was designed to investigate the potential of HPK1 inhibition as a mechanism to re-establish T cell-mediated cytotoxicity against tumour cells.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
AZ3246 exhibits lower potency inhibition of the closely related HPK1 enzyme GLK (MAP4K3; IC50 220 nM) compared to HPK1 [1]. It inhibits phosphorylation of the HPK1 substrate SLP76 (IC50 82 nM) and induces production of IL-2 by human T cells (EC50 110 nM). AZ3246 is active in vivo, inducing antitumour activity in the EMT6 syngeneic mouse breast tunour model |
Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|